Skip to Main content Skip to Navigation
Journal articles

Metabolic Diseases and Down Syndrome: How Are They Linked Together?

Abstract : Down syndrome is a genetic disorder caused by the presence of a third copy of chromosome 21, associated with intellectual disabilities. Down syndrome is associated with anomalies of both the nervous and endocrine systems. Over the past decades, dramatic advances in Down syndrome research and treatment have helped to extend the life expectancy of these patients. Improved life expectancy is obviously a positive outcome, but it is accompanied with the need to address previously overlooked complications and comorbidities of Down syndrome, including obesity and diabetes, in order to improve the quality of life of Down syndrome patients. In this focused review, we describe the associations between Down syndrome and comorbidities, obesity and diabetes, and we discuss the understanding of proposed mechanisms for the association of Down syndrome with metabolic disorders. Drawing molecular mechanisms through which Type 1 diabetes and Type 2 diabetes could be linked to Down syndrome could allow identification of novel drug targets and provide therapeutic solutions to limit the development of metabolic and cognitive disorders.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-03183936
Contributor : Inrae Breed <>
Submitted on : Monday, March 29, 2021 - 9:45:37 AM
Last modification on : Friday, September 3, 2021 - 10:10:01 AM

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Links full text

Identifiers

Citation

Manon Moreau, Soukaina Benhaddou, Rodolphe Dard, Stefania Tolu, Rim Hamzé, et al.. Metabolic Diseases and Down Syndrome: How Are They Linked Together?. Biomedicines, MDPI, 2021, 9 (2), pp.221. ⟨10.3390/biomedicines9020221⟩. ⟨hal-03183936⟩

Share

Metrics

Record views

79